Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care 2011; 34: 703 709. 68. Thomas MC, Moran J, Forsblom C et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011; 34: 861 866. 69. Chen JL, Lerner D, Ruthazer R et al. Association of physical activity with mortality in chronic kidney disease. J Nephrol 2008; 21: 243 252. 70. O Hare AM, Tawney K, Bacchetti P et al. Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2. Am J Kidney Dis 2003; 41: 447 454. 71. Stack AG, Molony DA, Rives T et al. Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis 2005; 45: 690 701. 72. World Health Organization. International Guide for Monitoring Alcohol Consumption and Related Harm. 2000. 73. Jee SH, Miller ER, 3rd, Guallar E et al. The effect of magnesium supplemen- tation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002; 15: 691 696. 74. Campbell F, Dickinson HO, Critchley JA et al. A systematic review of fish-oil supplements for the prevention and treatment of hypertension. Eur J Prev Cardiol 2012 (in press). 75. Donadio JV, Jr., Bergstralh EJ, Offord KP et al. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 1994; 331: 1194 1199. 76. Swan SK, Olyaei A, Sica D. Clinical pharmacology for the nephrologist. NephSap 2010; 9: 220 264. 77. Agarwal R, Andersen MJ. Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol 2006; 26: 503 510. 78. Davidson MB, Hix JK, Vidt DG et al. 